오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - feline calicivirus - inactivated; chlamydophilia felis inactivated; feline panleucopenia virus - inactivated; feline rhinotracheitis virus - inactivated; amphotericin; neomycin; polymyxin b; thiomersal - misc. vaccines or anti sera - feline calicivirus - inactivated vaccine-viral active 0.0 p; chlamydophilia felis inactivated vaccine-viral active 0.0 p; feline panleucopenia virus - inactivated vaccine-viral active 0.0 p; feline rhinotracheitis virus - inactivated vaccine-viral active 0.0 p; amphotericin antibiotic other 1.36 ug/ml; neomycin antibiotic other 12.0 ug/ml; polymyxin b antibiotic other 20.0 iu/ml; thiomersal mercury other 68.0 ug/ml - immunotherapy - cat - over 8 weeks of age - feline calicivirus | feline chlamydia psittaci | feline enteritis | feline rhinotracheitis | vaccine | calicivirus (feline) | enteritis (feline) | equine rotavirus | fcv | feline herpesvirus type 1 | feline infectious enteritis | feline panleucopenia (fp) | fhv-1 | fvr | herpesvirus 1 (feline) | herpesvirus type 1 (feline) | panleucopenia (feline) | rhinotracheitis (feline)

오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - feline calicivirus; live feline herpes virus - misc. vaccines or anti sera - feline calicivirus vaccine-viral active 4.6 pfu/dose; live feline herpes virus vaccine-viral active 4.8 pfu/dose - immunotherapy - cat | cat - queen | cat - tom | kitten - feline calicivirus | feline rhinotracheitis | calicivirus (feline) | fcv | feline herpesvirus type 1 | fhv-1 | fvr | herpesvirus 1 (feline) | herpesvirus type 1 (feline) | rhinotracheitis (feline)

필리핀 - 영어 - FDA (Food And Drug Administration)

msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - live attenuated feline calicivirus (fcv) , feline viral rhinotracheitis virus (fvr) , feline panleukopenia virus (fpl) vaccine (vet.) - suspension for injection (sc) - formulation: each dose contains: feline calicivirus (f9 strain) .....>4.6 log10 pfu feline viral rhinotracheitis virus (g2620a strain) ................>5.2 log10 pfu feline panleucopenia virus (mw-1 strain) .............>4.3 log10 tcid pfu-plaque forming unit tcid-tissue culture infective dose

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

elanco animal health, eli lilly and company limited - feline enteritis (panleucopenia) virus (fpv), snow leopard strain live attenuated, feline rhinotracheitis virus (fvr), strain fvrm live attenuated, feline calicivrus, strain f9 live attenuated - lyophilisate and solvent for solution for injection - unknown - feline panleucopenia virus / parvovirus vaccine + feline rhinotracheitis virus vaccine + feline cal - feline - immunological - live vaccine

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

intervet ireland limited - feline calicivrus, strain f9 live attenuated, feline herpes virus type 1, strain g2620a live attenuated, feline panleucopenia virus, strain mw-1 live attenuated - lyophilisate and solvent for suspension for injection - unknown - feline panleucopenia virus / parvovirus vaccine + feline rhinotracheitis virus vaccine + feline cal - feline - immunological - live vaccine

유럽 연합 - 영어 - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals for felidae, - cats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease.onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component.the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

유럽 연합 - 영어 - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - immunologicals for felidae, - cats - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs.onsets of immunity have been demonstrated one week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components.the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

유럽 연합 - 영어 - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - immunologicals for felidae, - cats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease.onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component.the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

뉴질랜드 - 영어 - Ministry for Primary Industries

schering-plough animal health ltd - feline chlamydia psittaci strain baker; feline calici virus (attenuated); feline panleucopenia virus (attenuated); feline rhinotracheitis virus (attenuated) - feline chlamydia psittaci strain baker 0 vaccine; feline calici virus (attenuated) 0 vaccine; feline panleucopenia virus (attenuated) 0 vaccine; feline rhinotracheitis virus (attenuated) 0 vaccine - vaccine

뉴질랜드 - 영어 - Ministry for Primary Industries

schering-plough animal health limited - feline calici virus (attenuated); feline panleucopenia virus (attenuated); feline rhinotracheitis virus (attenuated) - feline calici virus (attenuated) 0 vaccine; feline panleucopenia virus (attenuated) 0 vaccine; feline rhinotracheitis virus (attenuated) 0 vaccine - vaccine